Study Suggests Fatty Liver and Cirrhosis Doubles Mortality Risk in COVID-19 – StartupWorld

1 min read
At Digital International Liver Congress, the experts have presented evidence that suggests that patient with a history of liver diseases like cirrhosis or non-alcoholic fatty liver disease poses a higher risk to mortality and morbidity with COVID-19.
Study Suggests Fatty Liver and Cirrhosis Doubles Mortality Risk in COVID-19 – StartupWorld

At Digital International Liver Congress, the experts have presented evidence that suggests that patient with a history of liver diseases like cirrhosis or non-alcoholic fatty liver disease poses a higher risk to mortality and morbidity with COVID-19.
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *